Bruker Corporation

NASDAQ:BRKR

Medical - Devices

Healthcare
$63.26 -1.92%

-$1.07 today

Market cap
$9.66B
Beta
1.30
P/E (TTM)
-718.1
EPS (TTM)
-$0.08
Dividend yield
0.37%
52W Low $28.53High $64.54

Volume 1.73M

Average 2.41M

BRKR Pre-Tax Margin

Income before tax as a percentage of revenue.

Bruker CorporationNASDAQ: BRKR

Pre-Tax Margin · Q2 FY2026 · quarter ended Jun 2026

Pre-tax margin narrows to -4.9%

Pre-tax margin was -4.9% in Q2 FY2026, down 5.0 pp from a year earlier. On a trailing-twelve-month basis it was -0.8%, down 4.8 pp year over year. Over 3 fiscal years it narrowed by 15.8 pp.

Context

  • Pre-tax margin widened in 1 of the last 3 fiscal years.
  • FY2025 was the lowest level in the 4 fiscal years shown.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterJun 2026
-4.9%-7.1 pp QoQ
Last fiscal yearDec 2025
0.6%-5.5 pp YoY
LTMJun 2026
-0.8%-4.8 pp YoY
Pre-Tax Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter-5.0 pp——
1 year-5.5 pp——
3 years-15.8 pp——
5 years——
10 years——

Pre-Tax Margin history

Percent of revenue · from the income statement

Latest · FY2025
0.6%
Year-over-year change
-5.5pp

Pre-Tax Margin vs competitors

How BRKR compares with its peers on the latest reported figures

  • BRKR's LTM Jun 2026 pre-tax margin of -0.8% is the 10th highest of the 11 companies compared; the peer median is 17.6%.
  • Its year-over-year change of -4.8 pp is the 10th highest of 11, against a peer median of +0.2 pp.
  • Over three fiscal years its change of -15.8 pp compares with a peer median of -2.8 pp.
BRKR Competitors Peer median
Pre-Tax Margin for BRKR and competitors
Company Period LTM level YoY 3-year change
MTDMettler-Toledo International Inc.LTM Jun 202626.5% +0.1 pp-1.3 pp
AAgilent Technologies, Inc.LTM Jul 202622.5% +2.0 pp-1.3 pp
QGENQiagen N.V.LTM Jun 202622.0% -2.0 pp-0.5 pp
DHRDanaher CorporationLTM Sep 202618.8% +1.6 pp-9.6 pp
TECHBio-Techne CorporationLTM Sep 202618.5% +9.8 pp-10.0 pp
TMOThermo Fisher Scientific Inc.LTM Sep 202616.6% +0.3 pp-0.8 pp
BIOBio-Rad Laboratories, Inc.LTM Jun 202613.5% -4.1 pp+206.4 pp
RVTYRevvity, Inc.LTM Jul 20269.0% -2.3 pp-10.3 pp
WATWaters CorporationLTM Jul 20264.4% -21.6 pp-4.3 pp
BRKRBruker CorporationLTM Jun 2026-0.8% -4.8 pp-15.8 pp
PACBPacific Biosciences of California, Inc.LTM Mar 2026-79.8% +351.9 pp-96.4 pp
Peer median (excluding BRKR) 17.6%+0.2 pp-2.8 pp

Competitors are the stored peer set for BRKR. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue2.42B2.53B2.96B3.37B3.44B
Cost of Revenue1.21B1.23B1.45B1.72B1.86B
Gross Profit1.21B1.31B1.51B1.65B1.58B
Gross Margin50.0%51.6%51.0%49.0%45.9%
Research & Development220.8M235.9M294.8M376.5M395.2M
Selling, General & Admin562.3M607.4M729.4M893.8M946.5M
Operating Expenses796.3M873M1.08B1.4B1.34B
Depreciation & Amortization89.1M88.7M114.9M183.8M220.3M
EBITDA497M518.7M675.5M438.6M302.6M
EBITDA Margin20.6%20.5%22.8%13.0%8.8%
Operating Income413.3M432.7M436.9M253.1M236M
Operating Margin17.1%17.1%14.7%7.5%6.9%
Interest Income900K2.8M7.5M9.3M14.8M
Interest Expense14.3M16.1M16.4M47.9M60.3M
Other Income / Expenses(19.7M)(17.8M)109.3M(47.9M)(215M)
Income Before Tax393.6M414.9M546.2M205.2M21M
Pre-Tax Margin16.3%16.4%18.4%6.1%0.6%
Income Tax Expense113M116.4M117.7M91.4M29.3M
Net Income277.1M296.6M427.2M113.1M(8.6M)
Net Margin11.5%11.7%14.4%3.4%-0.3%
EPS (Basic)1.832.002.920.76(0.15)
EPS (Diluted)1.811.992.900.76(0.15)
Weighted Avg Shares151.4M148.6M146.4M149M151.8M
Weighted Avg Shares (Diluted)152.9M149.4M147.2M149.5M151.8M

Bruker Corporation

NASDAQ:BRKR

Intrinsic Alpha fair value

Locked

Current Price

$63.26

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.